2014
DOI: 10.15252/embr.201439245
|View full text |Cite
|
Sign up to set email alerts
|

Senescence and apoptosis: dueling or complementary cell fates?

Abstract: In response to a variety of stresses, mammalian cells undergo a persistent proliferative arrest known as cellular senescence. Many senescence-inducing stressors are potentially oncogenic, strengthening the notion that senescence evolved alongside apoptosis to suppress tumorigenesis. In contrast to apoptosis, senescent cells are stably viable and have the potential to influence neighboring cells through secreted soluble factors, which are collectively known as the senescence-associated secretory phenotype (SASP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

19
591
0
4

Year Published

2016
2016
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 673 publications
(619 citation statements)
references
References 143 publications
19
591
0
4
Order By: Relevance
“…Of note, senescence can be an alternative route to curb tumor growth where cells get resistance to apoptosis. Generally, apoptosis is a programmed cell death, but an apoptotic cell does not communicate with the surrounding cells, whereas, in contrast to apoptosis, a senescent cell can activate a paracrine signaling within the tumor contributing more benefits than apoptosis (Childs et al 2014;Hoare and Narita 2013). This report suggests that cristacarpin could be considered as a potential lead for senescence induction in cancer cells.…”
Section: Discussionmentioning
confidence: 84%
“…Of note, senescence can be an alternative route to curb tumor growth where cells get resistance to apoptosis. Generally, apoptosis is a programmed cell death, but an apoptotic cell does not communicate with the surrounding cells, whereas, in contrast to apoptosis, a senescent cell can activate a paracrine signaling within the tumor contributing more benefits than apoptosis (Childs et al 2014;Hoare and Narita 2013). This report suggests that cristacarpin could be considered as a potential lead for senescence induction in cancer cells.…”
Section: Discussionmentioning
confidence: 84%
“…Resistance to apoptosis and oxidative stress is a hallmark of SCs (Childs, Baker, Kirkland, Campisi & Van Deursen, 2014; Childs et al., 2017) that can be exploited to develop senolytic agents that selectively kill SCs, assuming that the molecules that mediate the resistance can be identified. Indeed, we and others have recently discovered that the upregulation of the antiapoptotic Bcl‐2 family proteins is primarily responsible for the resistance of SCs to apoptosis, and Bcl‐2/xl/w inhibitors such as ABT‐263 are potent senolytic agents (Chang et al., 2016; Yosef et al., 2016; Zhu et al., 2016).…”
Section: Discussionmentioning
confidence: 99%
“…Actually, senescent cells might maintain an apparent homeostasis by eliminating oversynthesized factors such as those observed in the SASP. SASP has been shown to contribute to the pro-tumorigenic effect of senescence, 41,42 including in MM. 16 Therefore, preventing SASP in MM might lead to a decreased tumorigenesis.…”
Section: Discussionmentioning
confidence: 99%